Comparative analysis of patients with CLL EBV+ and CVID EBV+ also showed a number of significant statistical changes in almost all analyzed percentages of T and B lymphocytes positively expressing all tested immunological checkpoints and their ligands, with the exception of CD8+ CD200R+ (Table 5). Here, CD200R1 is linked to B-cell chronic lymphocytic leukemia.